RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

The companies Cogent Biosciences, Braveheart Bio, and AAVantgarde bagged the biggest biotech funding rounds overall in ...

SciNeuro Pharmaceuticals represents the latest in a string of Arch investments directed at the nervous system, a notoriously ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

Management has positioned bezuclastinib as a potential alternative to Blueprint Medicines' (BPMT) Ayvakit. This PDGFRα/c-KIT ...

The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. This drugmaker has a strong ...

French biotech company Abivax SA started the year with a market value of less than $500 million. After a meteoric rally, it’s ...

Pfizer’s VC arm has backed a $100 million series A raise for OTR Therapeutics, as the Chinese biotech tacks on preclinical ...

A decades-old way to bridge buyers and sellers on price, contingent value rights have recently seen an uptick in use due to a ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

B ay Area startup ASC Therapeutics filed for bankruptcy on Wednesday, marking the end of the line for the gene and cell therapy researcher even as Health and Human Services Secretary Robert F. Kennedy ...

As of Tuesday, December 02, Vir Biotechnology, Inc.’s VIR share price has dipped by 8.57%, which has investors questioning if ...